Form D — Aminex Therapeutics, Inc.
0001470831-25-000383 · filed 2025-12-05
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $30,000,030
- Total sold
- $15,084,670
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aminex Therapeutics, Inc.
- CIK
- 1613386
- Entity
- Corporation
- Jurisdiction
- WASHINGTON
- Year incorporated
- —
- Address
- 6830 NE Bothell Way Ste C139
Kenmore, WA 98028 - Phone
- 425-286-4222
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Meeks · DirectorKenmore, WA Find on LinkedIn ↗
-
Mark Burns · Executive OfficerKenmore, WA Find on LinkedIn ↗
-
Don Dyer · DirectorKenmore, WA Find on LinkedIn ↗
-
Jeffrey Miller · DirectorKenmore, WA Find on LinkedIn ↗
-
Deyaa Adib · DirectorKenmore, WA Find on LinkedIn ↗
-
James Skaggs · DirectorKenmore, WA Find on LinkedIn ↗
View original on SEC EDGAR.